Loading insider details...
Latest Form 4 (Jul 13, 2026): Sale of 33,936 MLTX shares, $679.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 33,936 | $679.1K |
| Jul 2, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 47,775 | $956.9K |
| Apr 14, 2026 | MoonLake Immunotherapeutics (MLTX) | Sale | 98,127 | $1.81M |
| Jan 9, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 520,342 | n/a |
| Dec 22, 2025 | MoonLake Immunotherapeutics (MLTX) | Conversion | 196,316 | n/a |
| Dec 10, 2025 | MoonLake Immunotherapeutics (MLTX) | Sale | 130,000 | $1.96M |
| Mar 4, 2025 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 95,763 | n/a |
| Mar 1, 2024 | MoonLake Immunotherapeutics (MLTX) | Sale | 62,810 | $3.45M |
| Feb 23, 2024 | MoonLake Immunotherapeutics (MLTX) | Sale | 1,125 | $62.2K |
| Feb 20, 2024 | MoonLake Immunotherapeutics (MLTX) | Sale | 20,000 | $1.20M |